Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 146.61%4M | 208.00%2.7M | 37.13%1.72M | 28.01%5.88M | 64.35%2.13M | 19.35%1.62M | -8.76%875K | 27.93%1.26M | 90.43%4.6M | 106.37%1.3M |
| Operating revenue | 146.61%4M | 208.00%2.7M | 37.13%1.72M | 28.01%5.88M | 64.35%2.13M | 19.35%1.62M | -8.76%875K | 27.93%1.26M | 90.43%4.6M | 106.37%1.3M |
| Cost of revenue | 13.49%656K | 7.10%558K | -34.86%497K | 5.02%2.51M | -6.10%647K | -26.56%578K | 1.36%521K | 91.23%763K | 32.21%2.39M | 70.97%689K |
| Gross profit | 220.31%3.34M | 503.67%2.14M | 148.78%1.22M | 52.90%3.37M | 144.32%1.48M | 82.52%1.04M | -20.45%354K | -15.46%492K | 264.03%2.21M | 169.78%607K |
| Operating expense | 0.96%1.88M | 17.52%1.91M | -18.77%1.45M | 9.24%7.85M | 21.38%2.58M | 24.98%1.87M | -9.36%1.63M | 0.28%1.78M | 6.18%7.19M | 10.00%2.12M |
| Selling and administrative expenses | 0.96%1.88M | 17.52%1.91M | -18.77%1.45M | 9.24%7.85M | 21.38%2.58M | 24.98%1.87M | -9.36%1.63M | 0.28%1.78M | 6.18%7.19M | 10.00%2.12M |
| -General and administrative expense | 0.96%1.88M | 17.52%1.91M | -18.77%1.45M | 9.24%7.85M | 21.38%2.58M | 24.98%1.87M | -9.36%1.63M | 0.28%1.78M | 6.18%7.19M | 10.00%2.12M |
| Operating profit | 277.62%1.46M | 117.67%225K | 82.83%-221K | 10.10%-4.48M | 27.84%-1.09M | 10.75%-822K | 5.70%-1.27M | -7.97%-1.29M | 19.19%-4.98M | 11.09%-1.52M |
| Net non-operating interest income (expenses) | 31.43%-397K | 4.46%-535K | 10.36%-528K | -68.31%-2.32M | -29.52%-588K | -209.63%-579K | -44.70%-560K | -69.25%-589K | 3.44%-1.38M | -31.21%-454K |
| Non-operating interest expense | -27.33%359K | -4.42%454K | -11.11%448K | 68.97%1.98M | 30.91%504K | 285.94%494K | 38.89%475K | 60.00%504K | -9.09%1.17M | 23.00%385K |
| Total other finance cost | -55.29%38K | -4.71%81K | -5.88%80K | 64.56%339K | 21.74%84K | 44.07%85K | 88.89%85K | 157.58%85K | 49.28%206K | 109.09%69K |
| Other net income (expenses) | -116.22%-60K | -463.20%-1.29M | -72.08%43K | -27.20%1.37M | 151.55%488K | 137.30%370K | -84.48%356K | -59.79%154K | 156.94%1.88M | 106.99%194K |
| Gain on sale of security | 17.89%-78K | -233.80%-475K | -114.29%-32K | 47.93%1.11M | 220.10%621K | -140.60%-95K | 607.14%355K | -42.42%224K | 31.75%747K | 377.14%194K |
| Special income (charges) | --0 | ---738K | ---- | --0 | --0 | --0 | --0 | ---- | 132.59%1.08M | 88.19%-241K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | -35.66%2.36M | --0 |
| -Less:Other special charges | ---- | --738K | ---- | ---- | ---- | ---- | ---- | ---- | 579.19%1.66M | --241K |
| -Gain on sale of business | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --5.09M | --0 |
| Other non-operating income (expenses) | -108.16%-35K | -364.00%-116K | 144.71%38K | 752.17%150K | -173.80%-169K | 311.33%429K | 13.79%-25K | -325.00%-85K | -163.89%-23K | 663.33%229K |
| Income before tax | 197.28%1M | -8.53%-1.6M | 59.00%-706K | -21.18%-5.42M | 32.77%-1.19M | 50.90%-1.03M | -365.17%-1.48M | -48.83%-1.72M | 58.88%-4.48M | 63.21%-1.78M |
| Income tax | 171.01%374K | 850.00%133K | 150.00%25K | -96.18%52K | -220.88%-110K | 411.11%138K | -98.66%14K | -94.97%10K | 3,140.48%1.36M | 327.50%91K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 153.81%629K | -16.43%-1.74M | 57.79%-731K | 6.18%-5.48M | 41.94%-1.08M | 45.04%-1.17M | -206.16%-1.49M | -27.73%-1.73M | 46.59%-5.84M | 61.01%-1.87M |
| Net income continuous operations | 153.81%629K | -16.43%-1.74M | 57.79%-731K | 6.18%-5.48M | 41.94%-1.08M | 45.04%-1.17M | -206.16%-1.49M | -27.73%-1.73M | 46.59%-5.84M | 61.01%-1.87M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 153.81%629K | -16.43%-1.74M | 57.79%-731K | 6.18%-5.48M | 41.94%-1.08M | 45.04%-1.17M | -206.16%-1.49M | -27.73%-1.73M | 46.59%-5.84M | 61.01%-1.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 153.81%629K | -16.43%-1.74M | 57.79%-731K | 6.18%-5.48M | 41.94%-1.08M | 45.04%-1.17M | -206.16%-1.49M | -27.73%-1.73M | 46.59%-5.84M | 61.01%-1.87M |
| Diluted earnings per share | 200.00%0.01 | 0.00%-0.02 | 50.00%-0.01 | 45.45%-0.06 | 66.67%-0.01 | 75.00%-0.01 | -100.00%-0.02 | 33.33%-0.02 | 54.17%-0.11 | 70.00%-0.03 |
| Basic earnings per share | 200.00%0.01 | 0.00%-0.02 | 50.00%-0.01 | 45.45%-0.06 | 66.67%-0.01 | 75.00%-0.01 | -100.00%-0.02 | 33.33%-0.02 | 54.17%-0.11 | 70.00%-0.03 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.